Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF.

导出 LinkOut

翻译打印收藏纠错

作者： Jonathan J,Passeri ^[1] ; Sammy,Elmariah ^[2] ; Ke,Xu ^[3] ; Ignacio,Inglessis ^[1] ; Joshua N,Baker ^[4] ; Maria,Alu ^[3] ; Susheel,Kodali ^[3] ; Martin B,Leon ^[3] ; Lars G,Svensson ^[5] ; Philippe,Pibarot ^[6] ; William F,Fearon ^[7] ; Ajay J,Kirtane ^[3] ; Gus J,Vlahakes ^[4] ; Igor F,Palacios ^[1] ; Pamela S,Douglas ^[8] ; PARTNER Investigators

作者单位： Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. ^[1] Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA Harvard Clinical Research Institute, Boston, Massachusetts, USA. ^[2] Columbia University Medical Center/New York-Presbyterian Hospital, The Cardiovascular Research Foundation, New York, New York, USA. ^[3] Department of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. ^[4] Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA. ^[5] Québec Heart and Lung Institute, Laval University, Québec, Canada. ^[6] Stanford University School of Medicine, Stanford, California, USA. ^[7] Duke Clinical Research Institute/Duke University Medical Center, Durham, North Carolina, USA. ^[8]